BSSP (Cantech Holding) Other Operating Expense: $0.04 Mil (TTM As of Sep. 2015)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cantech Holding Other Operating Expense?

Cantech Holding BSSP -99.50% Other Operating Expense is $0.04 Mil as of Sep. 2015.

Cantech Holding's Other Operating Expense for the three months ended in Sep. 2015 was $0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2015 was $0.04 Mil.

Cantech Holding's annual Other Operating Expense declined from Dec. 2012 ($0.00 Mil) to Dec. 2013 ($-0.00 Mil) but then increased from Dec. 2013 ($-0.00 Mil) to Dec. 2014 ($0.00 Mil).

Cantech Holding Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Cantech Holding's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantech Holding Other Operating Expense Chart

Cantech Holding Annual Data
Trend Dec11 Dec12 Dec13 Dec14
Other Operating Expense
0.00 0.00 -0.00 0.00

Cantech Holding Quarterly Data
Sep10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.04 0.00 0.00 0.00

Cantech Holding Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $0.04 Mil mean?
Cantech Holding (BSSP) has a Other Operating Expense of $0.04 Mil as of Sep. 2015. Other operating expenses that a company records on its income statement. View historical data on Cantech Holding and its competitors.
Is Cantech Holding's Other Operating Expense too high?
Cantech Holding's current Other Operating Expense is $0.04 Mil.
How does Cantech Holding's Other Operating Expense compare to HSTC and NTRR?
Cantech Holding's Other Operating Expense of $0.04 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Cantech Holding and its competitors. Cantech Holding's current Other Operating Expense is $0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantech Holding stock overvalued right now?
Cantech Holding (BSSP) has a current Other Operating Expense of $0.04 Mil. The current Other Operating Expense is $0.04 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Cantech Holding (BSSP), the current Other Operating Expense is $0.04 Mil as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantech Holding Business Description

Address 120 W Pomona Avenue, Monrovia, CA, USA, 91016
Cantech Holding Inc is a development stage immunotherapeutic-based technology company. Principally, it is focused on commercialization of its proprietary proteins for the treatment of cancer and various infectious diseases. Its Irreversible Pepsine Fraction (IPF) is a therapeutic platform technology that can be used to facilitate varieties of applications. The company's product consists of IMMUNE-THERAPEUTIC PROTEIN which is a therapeutic protein isolated from porsine pepsin and is irreversible, modified, and fractionated to the sequence IPF.